In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Aromasin Drug Master File in Korea (Aromasin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Aromasin. The MFDS reviews the Aromasin KDMF as part of the drug registration process and uses the information provided in the Aromasin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Aromasin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Aromasin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Aromasin suppliers with KDMF on PharmaCompass.